The US government rested its case against Facebook-owner Meta on Thursday, as it tries to persuade a US judge that the tech ...

Members of the House Judiciary Subcommittee on the Administrative State, Regulatory Reform and Antitrust debated Wednesday ...

One of President Trump’s top antitrust cops made it clear this week that the new administration is going to aggressively ...

The Trade Desk's ongoing transition with Kokai already delivered robust FQ1'25 performance and promising FQ2'25 guidance. See ...

The Federal Trade Commission wrapped up its case for breaking up Meta Platforms Inc. as an illegal social-media monopoly, ...

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has ...

Google faces civil lawsuits totaling at least €12 billion (over $13 billion) in Europe following a European Commission ruling ...

Major companies that curtailed advertising on Elon Musk’s social media platform X over concerns about its ability to control ...

In a legal filing, advertisers sued by X said the suit was an attempt to use the courthouse win back business it lost.

Regeneron Pharmaceuticals won $406.8 million in damages for a lawsuit claiming Amgen violated antitrust and tort laws. A jury in a Delaware court found that Amgen violated certain laws, and gave ...

Google urges a Texas court to disregard a Virginia ruling declaring its ad business a monopoly, as it battles multiple antitrust lawsuits across the U.S., Technology & Science News - Times Now ...

The government showed hundreds of internal documents as it sought to prove that the social media company bought Instagram and ...